Acumen Pharmaceuticals's total assets for Q4 2025 were $122.83M, a decrease of -13.63% from the previous quarter. ABOS total liabilities were $52.40M for the fiscal quarter, a 6.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.